서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Subject

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 16 of 16

Issue DateTitle / Author(s) / CitationFileAltmetrics
1997-07
Expression of transforming growth factor β type II receptor reduces tumorigenicity in human gastric cancer cells

Chang, Jay; Park, Keunchil; Bang, Yung-Jue; Kim, Won Seog; Kim, David; Kim, Seong-Jin

Cancer Research, Vol.57 No.14, pp.2856-2859

1997-09
Mutational analysis of the hMSH2 gene in a wide variety of tumors

Hatta, Y; Wada, M; Takeuchi, S; Tasaka, T; Lee, E; Lee, YY; Kim, BK; Bang, YJ; Lee, S; Yamada, Y; Tomonaga, M; Wilczynski, SP; Said, JW; Koeffler, HP

International Journal of Oncology, Vol.11 No.3, pp.465-469

DOI
1998-01
A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-β type II receptor
DOI
1998-08
Genetic integrity of transforming growth factor beta (TGF-beta) receptors in cervical carcinoma cell lines: Loss of growth sensitivity but conserved transcriptional response to TGF-beta
DOI
1999-04
Truncation of the TGF-β type II receptor gene results in insensitivity to TGF-β in human gastric cancer cells
DOI
1999-12
Transcriptional repression of the transforming growth factor-β type I receptor gene by DNA methylation results in the development of TGF-β resistance in human gastric cancer
DOI
2000-03
Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis

Kim, SJ; Im, YH; Markowitz, SD; Bang, YJ

Cytokine and Growth Factor Reviews, Vol.11 No.1-2, pp.159-168

DOI
2001-06
Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5′ CpG island in human gastric carcinoma cells
2004-02
Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer
DOI
2004-07
DNA hypermethylation in gastric cancer

Kim, T. Y.; Jong, H. S.; Jung, Y.; Kim, T. Y.; Kang, G. H.; Bang, Y. J.

Alimentary Pharmacology and Therapeutics, Vol.20 No.1, pp.131-142

DOI
2011-06
The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010
DOI
2015-07
Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX
view fileDOI
2016-07
Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer
DOI
2020-02
Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
DOI
2021-01
Expression of human leukocyte antigen class I and beta 2-microglobulin in colorectal cancer and its prognostic impact
DOI
2021-08
Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts
DOI
1